´ëÇÑÇ÷°ü¿Ü°úÇÐȸ The 13th Seoul Bi-Vascular Symposium : 2023-03-25
±³À°ÀÏÀÚ : 2023-03-25
±³À°Àå¼Ò : The K È£ÅÚ ±Ý°È¦
±³À°ÁÖÁ¦ : The 13th Seoul Bi-Vascular Symposium
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Bi-vascular
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227
À̸ÞÀÏ : bivascular@naver.com
±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 58ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ/ÀϹÝÀÇ/°øº¸ÀÇ/±ºÀÇ°ü: »çÀü:20,000¿ø, ÇöÀå:50,000¿øÀüÀÓÀÇ/Àü°øÀÇ/±âŸ: »çÀü: ¹«·á, ÇöÀå: 20,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:00~09:15 Recorded live case 1: FEVAR William J Yoon(Case Western Reserve Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:15~09:30 Recorded live case 2: Treatment for chronic type B aortic dissection ÀÓ¼ºÈ£(Rush Univ Medical Center USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:30~09:36 Has the NICE guideline for AAA changed the AAA practice pattern? ¾ç½Å¼®(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:36~09:42 What will be the last one standing fEVAR, chEVAR, ESAR, or OSAR? William J Yoon(Case Western Reserve Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:42~09:48 Current EVARs are performed on AAAs smaller than the guideline recommends, Are ruler takers just blind? ÀüÈ︸(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:48~09:54 Small AAA are not all the same, The gray zone of guideline Daniel K. Han(Mount Sinai Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 09:54~10:00 The optimal treatment of aortic and graft Infections and alternative options (when is percutaneous drainage acceptable) Çã½Â(°æºÏÀÇ´ë)
Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 10:00~10:30 Discusion ()
ÈÞ½Ä 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 10:50~11:05 Recorded live case 3: Complex aortoiliac obstructions endo Jayer Chung(Baylor Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:05~11:20 Recorded live case 4: Pedal bypass ¾ÈÇüÁØ(°æÈñÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:20~11:26 Technical tips for successful EVT in AIOD Á¶ÁøÇö(°æÈñÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:26~11:32 Chronic flush juxtarenal aortic occlusion do need open bypass and technical tips Á¶¿ëÇÊ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:32~11:38 Severely calcified CTO in SFA: What to do? Is atherectomy and DCB the best combination? Cheong Jun Lee(Northshore Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:38~11:44 How to change practice after BEST-CLI report? ÀÌŽÂ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:44~11:50 Clinical scenarios when open bypass is preferred than endo ÇÑ¿µÁø(¿ï»êÀÇ´ë)
Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 11:50~12:20 Discussion ()
½Ä»ç 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 12:20~13:30 lunch ()
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 13:30~13:37 Problems after EVAR can be treated with endovascular therapy ÀÌ»ó¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 13:37~13:44 Early open conversion is more cost-effective than repeated interventions ÀÓ¼ºÈ£(Rush Univ Medical Center USA)
Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 13:44~14:04 Discussion ()
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 14:04~14:11 Regularly checking the VA by ultrasound is not necessary ¹Ú»óÁØ(¿ï»ê´ëº´¿ø)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 14:11~14:18 DUS as a screening tool for detecting stenosis and to perform preemptive interventions can prevent the loss of the AV access ±è´ëȯ(³ªÀº±æ¿Ü°ú)
Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 14:18~14:38 Discussion ()
ÈÞ½Ä 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 14:38~14:55 Coffee Break ()
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 14:55~15:01 How to be misled by RCTs And Meta-Analysis Flawed and Biased ±è¼¹Î(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 15:01~15:07 How can AI incorporate in Vascular field, and who will drive? ¾çµ¿Çö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 15:07~15:13 Rare disease consortium: K-RARE ¹Î½Â±â(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 15:13~15:19 How to make an optimal graft xenograft, peritoneum and new materials ÇѾƶ÷(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 15:19~15:25 The significance of endograft geometry on hemodynamics by using computational fluid dynamic analysis William J Yoon(Case Western Reserve Univ. USA)
Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 15:25~15:50 Discussion ()
ÈÞ½Ä 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 15:50~16:00 Coffee Break ()
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:00~16:06 Endovascular solution of PE When, why how À̸í¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:06~16:12 Percutaneous thromboembolectomy Which device to in certain clinical scenarios? Daniel K. Han(Mount Sinai Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:12~16:18 Endolymphatic intervention: How far have you been? Çã¼¼¹ü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:18~16:24 Practical combination for lowering LDL-C In Vascular Patients: New adjunctive drugs with statin °Áø¸ð(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:24~16:30 Wisdom of failure with new low profile endograft devices Cheong Jun Lee(Northshore Univ. USA)
±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:30~16:36 Hemodialysis access management after kidney transplantation ȲÁ¤±â(°¡Å縯ÀÇ´ë)
Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°È¦ 16:36~16:55 Discussion ()